Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications (CORONA-VTE NET)

NCT04535128 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT04535128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04535128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Registry to Assess Frequency, Risk Factors, Management, and Outcomes of Arterial and Venous Thromboembolic Complications (CORONA-VTE NET)
Lead sponsor
Brigham and Women's Hospital
Phase
Observational
Overall status
Completed
Start date
March 24, 2020
Completion date
August 31, 2025
Enrollment
11,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, dvt, myocardial infarction, pulmonary embolism, stroke, thrombosis embolism